Skip to content

Effectiveness and safety of hands-free bipolar radiofrequency device in submental fat reduction

Effectiveness and safety of hands-free bipolar radiofrequency device in submental fat reduction

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230124002
Enrollment
20
Registered
2023-01-24
Start date
2022-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effectiveness and safety of hands-free bipolar radiofrequency device in in patients with submittal fat Grade 2-4 Bipolar radiofrequency, Submental fat, Skin aging

Interventions

The hands-free bipolar radiofrequency device (EVOKE, Inmode aesthetics, USA) was used for treatment submental fat. The treatments protocol were assigned to subjects, each subject had totally 4 treatme
Experimental Device
Hands-free bipolar radiofrequency device

Sponsors

Institute of dermatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Both male and female subjects 2. BMI < 30 3. Patient with sagging and wrinkle skin on submental area4. submental fat Grade 2-4 by Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)

Exclusion criteria

Exclusion criteria: 1. Pregnancy women 2. Patient with photosensitivity 3. Patient with history of keloid and skin infection on submental fat area 4. Using cardiac PACE maker or antiplatelet

Design outcomes

Primary

MeasureTime frame
submental fat volume depletion at the last 4th treatment and 4 week , 8 week after final session 3D camera VECTRA and compared by computer program

Secondary

MeasureTime frame
Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) at baseline and each post treatment and 4 week , 8 week after final session 3D camera VECTRA and compared by computer program,Global aesthetic improvement scale (GAIS) at the last 4th treatment and 4 week , 8 week after final session by 3 blinded investigator ,Patient satisfaction score (PSS) at each post treatment and and 4 week , 8 week after final session evaluated by patient

Countries

Thailand

Contacts

Public Contactpurich kosidcanasup

Institute of dermatology

chin_22_chin@hotmail.com0891126772

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026